Thiazide diuretics exacerbate fructose-induced metabolic syndrome

107Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

Abstract

Fructose is a commonly used sweetener associated with diets that increase the prevalence of metabolic syndrome. Thiazide diuretics are frequently used in these patients for treatment of hypertension, but they also exacerbate metabolic syndrome. Rats on high-fructose diets that are given thiazides exhibit potassium depletion and hyperuricemia. Potassium supplementation improves their insulin resistance and hypertension, whereas allopurinol reduces serum levels of uric acid and ameliorates hypertension, hypertriglyceridemia, hyperglycemia, and insulin resistance. Both potassium supplementation and treatment with allopurinol also increase urinary nitric oxide excretion. We suggest that potassium depletion and hyperuricemia in rats exacerbates endothelial dysfunction and lowers the bioavailability of nitric oxide, which blocks insulin activity and causes insulin resistance during thiazide usage. Addition of potassium supplements and allopurinol with thiazides might be helpful in the management of metabolic syndrome. Copyright © 2007 by the American Society of Nephrology.

Cite

CITATION STYLE

APA

Reungjui, S., Roncal, C. A., Mu, W., Srinivas, T. R., Sirivongs, D., Johnson, R. J., & Nakagawa, T. (2007). Thiazide diuretics exacerbate fructose-induced metabolic syndrome. Journal of the American Society of Nephrology, 18(10), 2724–2731. https://doi.org/10.1681/ASN.2007040416

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free